论文部分内容阅读
目的总结我院抗血压药物的使用情况,为临床用药做合理参考。方法采用限定日剂量分析方法,对我院2010~2012年口服抗高血压药物的药品名称、销售金额、用药频度、日均费用等指标进行统计分析。结果近3年我院患者使用抗高血压药物销售金额前3位一直是钙离子拮抗剂(CCB)、血管紧张素受体阻滞剂(ARB)、血管紧张素转换酶抑制剂(ACEⅠ);用药频度前3位一直是CCB、利尿剂、ARB;单品种排序中销售金额前2位一直是硝苯地平控释片(拜新同)、氨氯地平片(络活喜),第3位2009年为左旋氨氯地平片,后由培哚普利片(雅施达)替代;用药频度前3位一直是硝苯地平控释片、氨氯地平片和螺内酯片。结论我院降压药物使用均符合标准。
Objective To summarize the use of antihypertensive drugs in our hospital and make reasonable reference for clinical medication. Methods A limited daily dose analysis method was used to conduct statistical analysis on the names, sales amount, frequency of medication, daily average cost and other indicators of oral antihypertensive drugs in our hospital from 2010 to 2012. Results The top 3 of antihypertensive drugs sold in our hospital in recent 3 years were all calcium channel blockers (ARBs) and angiotensin converting enzyme inhibitors (ACE Ⅰ). The first three of the frequency of medication has been CCB, diuretic, ARB; the top two in the sales amount of single variety sequencing has been nifedipine controlled release tablets (thanks to the new), amlodipine tablets 3 in 2009 for levamlodipine tablets, followed by perindopril tablets (Yasuda) replaced; medication frequency of the first 3 has been nifedipine controlled release tablets, amlodipine tablets and spironolactone tablets. Conclusion Our hospital use of antihypertensive drugs are in line with standards.